Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom.
Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
Can J Cardiol. 2024 May;40(5):833-842. doi: 10.1016/j.cjca.2023.12.001. Epub 2023 Dec 8.
Obstructive hypertrophic cardiomyopathy is the most common genetically transmitted cardiomyopathy that is associated with significant morbidity and mortality. Despite contemporary treatments and interventions, the management of patients with obstructive hypertrophic cardiomyopathy remains poorly defined compared with other branches of cardiology. In this review, we discuss established and novel therapeutic interventions in patients with obstructive hypertrophic cardiomyopathy with a focus on percutaneous and surgical strategies including surgical myectomy, mitral valve repair or replacement, percutaneous alcohol septal ablation, pacemaker and cardioverter-defibrillator implantation, septal embolization, radiofrequency endocardial catheter ablation, and percutaneous intramyocardial septal radiofrequency ablation.
梗阻性肥厚型心肌病是最常见的遗传性心肌病,与较高的发病率和死亡率相关。尽管有现代的治疗和干预手段,与心脏病学的其他分支相比,梗阻性肥厚型心肌病患者的管理仍然没有明确的定义。在这篇综述中,我们讨论了梗阻性肥厚型心肌病患者的既定和新型治疗干预措施,重点是经皮和手术策略,包括手术心肌切除术、二尖瓣修复或置换、经皮酒精室间隔消融术、起搏器和除颤器植入、间隔栓塞、射频心内膜导管消融术和经皮心肌内间隔射频消融术。